Please use this identifier to cite or link to this item: doi:10.22028/D291-44497
Title: Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
Author(s): Böhm, Michael
Butler, Javed
Filippatos, Gerasimos
Ferreira, João Pedro
Pocock, Stuart J.
Abdin, Amr
Mahfoud, Felix
Brueckmann, Martina
Gollop, Nicholas D.
Iwata, Tomoko
Ponikowski, Piotr
Wanner, Christoph
Zannad, Faiez
Packer, Milton
Anker, Stefan D.
Language: English
Title: Journal of the American College of Cardiology : JACC
Volume: 80
Issue: 1
Pages: 1-18
Publisher/Platform: Elsevier
Year of Publication: 2022
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Empagliflozin reduces cardiovascular death (CVD) or heart failure (HF) hospitalization (HFH) in patients with HF and preserved ejection fraction. Treatment effects and safety in relation to age have not been studied.
DOI of the first publication: 10.1016/j.jacc.2022.04.040
URL of the first publication: https://www.jacc.org/doi/10.1016/j.jacc.2022.04.040
Link to this record: urn:nbn:de:bsz:291--ds-444977
hdl:20.500.11880/39730
http://dx.doi.org/10.22028/D291-44497
ISSN: 0735-1097
Date of registration: 26-Feb-2025
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Michael Böhm
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes



This item is licensed under a Creative Commons License Creative Commons